↓ Skip to main content

Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice

Overview of attention for article published in Frontiers in immunology, October 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
37 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice
Published in
Frontiers in immunology, October 2022
DOI 10.3389/fimmu.2022.980189
Pubmed ID
Authors

Mohammad Reza Hatamnejad, Shaghayegh Baradaran Ghavami, Marzieh Shirvani, Mona Asghari Ahmadabad, Shabnam Shahrokh, Maryam Farmani, Ghazal Sherkat, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 8%
Student > Bachelor 2 5%
Researcher 2 5%
Student > Ph. D. Student 1 3%
Lecturer 1 3%
Other 2 5%
Unknown 26 70%
Readers by discipline Count As %
Medicine and Dentistry 5 14%
Biochemistry, Genetics and Molecular Biology 3 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Neuroscience 1 3%
Psychology 1 3%
Other 0 0%
Unknown 26 70%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2024.
All research outputs
#8,233,649
of 26,609,881 outputs
Outputs from Frontiers in immunology
#9,796
of 33,416 outputs
Outputs of similar age
#144,776
of 448,110 outputs
Outputs of similar age from Frontiers in immunology
#455
of 1,959 outputs
Altmetric has tracked 26,609,881 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 33,416 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.7. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,110 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 1,959 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.